Treatment of Bone Metastasis with Bone-Targeting Radiopharmaceuticals
Sign Up to like & getrecommendations! Published in 2018 at "Nuclear Medicine and Molecular Imaging"
DOI: 10.1007/s13139-017-0509-2
Abstract: Bone is a common metastatic site of cancer. Bone metastasis reduces life expectancy and results in serious symptoms and complications such as bone pain, pathological fractures, and spinal cord compression, decreasing quality of life by… read more here.
Keywords: bone targeting; treatment bone; targeting radiopharmaceuticals; bone ... See more keywords
The Emerging Role of PET/CT with PSMA-Targeting Radiopharmaceuticals in Clear Cell Renal Cancer: An Updated Systematic Review
Sign Up to like & getrecommendations! Published in 2023 at "Cancers"
DOI: 10.3390/cancers15020355
Abstract: Simple Summary Positron emission tomography/computed tomography (PET/CT) with prostate-specific membrane antigen (PSMA)-targeting radiopharmaceuticals is a relatively novel technique currently employed in the management of prostate cancer patients. These radiopharmaceuticals target PSMA, also known as carboxypeptidase… read more here.
Keywords: ccrcc; pet; targeting radiopharmaceuticals; psma targeting ... See more keywords
Diagnostic Accuracy of PET/CT or PET/MRI Using PSMA-Targeting Radiopharmaceuticals in High-Grade Gliomas: A Systematic Review and a Bivariate Meta-Analysis
Sign Up to like & getrecommendations! Published in 2022 at "Diagnostics"
DOI: 10.3390/diagnostics12071665
Abstract: Background: Several studies proposed the use of positron emission tomography (PET) with Prostate Specific Membrane Antigen (PSMA)-targeting radiopharmaceuticals in brain tumors. Our aim is to calculate the diagnostic accuracy of these methods in high-grade gliomas… read more here.
Keywords: pet mri; targeting radiopharmaceuticals; pet pet; psma targeting ... See more keywords
Can PSMA-Targeting Radiopharmaceuticals Be Useful for Detecting Hepatocellular Carcinoma Using Positron Emission Tomography? An Updated Systematic Review and Meta-Analysis
Sign Up to like & getrecommendations! Published in 2022 at "Pharmaceuticals"
DOI: 10.3390/ph15111368
Abstract: Background: Several studies proposed the use of positron emission tomography (PET) with Prostate-Specific Membrane Antigen (PSMA)-targeting radiopharmaceuticals in hepatocellular carcinoma (HCC). Our aim is to calculate the detection rate (DR) of this examination in HCC… read more here.
Keywords: targeting radiopharmaceuticals; hcc; meta analysis; psma targeting ... See more keywords
Introducing HDAC-Targeting Radiopharmaceuticals for Glioblastoma Imaging and Therapy
Sign Up to like & getrecommendations! Published in 2023 at "Pharmaceuticals"
DOI: 10.3390/ph16020227
Abstract: Despite recent advances in multimodality therapy for glioblastoma (GB) incorporating surgery, radiotherapy, chemotherapy and targeted therapy, the overall prognosis remains poor. One of the interesting targets for GB therapy is the histone deacetylase family (HDAC).… read more here.
Keywords: radiopharmaceuticals glioblastoma; introducing hdac; therapy; hdac targeting ... See more keywords